CARE
رعايةTechnical Analysis & Signals
Riyadah stock (4005.SR) shows positive signals under an uptrend, with clear support and resistance levels.
Technical Analysis
The stock is currently trading at SAR 130.7, with a positive change of 3.08%. The Relative Strength Index (RSI) is at 47.9, indicating that the stock may be in a neutral zone.
Support & Resistance Levels
The main support level is at SAR 126.4, while resistance is at SAR 135.13. A breakout above resistance could lead to further price increases.
Volume Analysis
The current trading volume may indicate increased activity, potentially reinforcing the uptrend. This trend is expected to continue if trading volume remains high.
Fundamental Factors
The price-to-earnings (P/E) ratio is 18.3, indicating a moderate valuation. The dividend yield at 1.58% may attract investors looking for steady income.
Risk Factors
The company may face risks related to fluctuations in the Saudi market and external economic impacts. It is important to monitor any changes in the overall economic conditions.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to conduct their own research before making any investment decisions.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - CARE
4005Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 5.84B
- P/E Ratio
- 18.30
- P/B Ratio
- 3.20
- EPS (Earnings/Share)
- 7.13
Profitability
- Revenue
- 1.60B
- Net Income
- 318.47M
- Return on Equity (ROE)
- +20.00%
- Shares Outstanding
- 44.69M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 516.03M
- Debt/Equity
- 0.28
- Free Float %
- +50.6%
Dividends & Margins
- Dividend Yield
- +1.58%
- Dividend/Share
- 2.00
- Book Value
- 40.84
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 1.60B +23.7% | 318.47M +8.1% | 2.77B +10.9% | 516.03M +5.8% | 7.13 +8.2% |
| 2024 | 1.29B +19.6% | 294.70M +22.3% | 2.50B +12.8% | 487.73M +47.7% | 6.59 +22.3% |
| 2023 | 1.08B +17.8% | 240.93M +41.7% | 2.21B +29.3% | 330.25M +297.0% | 5.39 +41.5% |
| 2022 | 917.93M | 170.07M | 1.71B | 83.19M | 3.81 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Care CEO says higher Q4 2025 topline fueled by patient visits
United Securities identifies 7 top Saudi picks for 2026
Care signs SAR 392M contract for MEP works at Al Narjis hospital
Care secures SAR 228.5M Murabaha financing from SAB
ANB Capital reviews Q4 2025 financials of four healthcare firms
AlJazira Capital issues Q4 2025 profit forecasts
Care plans capacity expansion, fresh strategy
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 249.10 SAR | |
| 4002 | Mouwasat | 71.10 SAR | |
| 4004 | Dallah Healthcare | 124.60 SAR | |
| 4017 | Fakeeh Care | 32.40 SAR | |
| 4018 | Almoosa | 137.10 SAR | |
| 4005 | CARE | 130.70 SAR | |
| 4019 | SMC Healthcare | 17.70 SAR | |
| 4007 | Alhammadi | 25.72 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-03-26
Risk Assessment
Risk Factors
Average True Range 4.2% of stock price
Trading volume below average
P/E ratio 18.3
Debt-to-equity ratio 0.28
ADX indicator at 29
Moderate risk factors with some sector pressures
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is CARE stock price today?
CARE (4005) stock price today is 130.70 SAR, gaining by +3.08% compared to the previous session close. The 52-week price range is between 110.80 SAR and 183.50 SAR.
2 What is CARE stock valuation?
The automated analysis signal for CARE is "Buy" with 70% confidence. The P/E ratio is 18.3. The P/B ratio is 3.20.
3 Is CARE Shariah-compliant?
Yes, CARE (4005) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are CARE dividend distributions?
CARE has a dividend yield of 1.58%, with an estimated annual dividend of 2.00 SAR per share.
5 What is CARE weekly performance?
CARE performance over different time periods: weekly change +2.43%, monthly -16.86%, and year-to-date -8.67%. The stock is currently trading with a volume of 134,800 shares.
6 What is the target level for CARE?
According to automated analysis for CARE: Short-term target (1-2 weeks): 135.00 SAR. Medium-term target (1-3 months): 150.00 SAR. Support level: 126.40 SAR. Resistance level: 135.13 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.